Blogs
The Strategic Advantage of Expert CRO Partnerships
Opyl hosted a thought-provoking webinar, The Strategic Advantage of Expert CRO Partnerships, featuring Associate Professor Tina Soulis from Alithia Life Sciences and […]
Read More 
AI Application Integrations for Trial Design and Operational Efficiency
TrialKey provides CROs with AI-driven biostatistical validation reports, optimising clinical trial success through data-driven insights and strategies.
Read More 
AI-Driven Biostatistical Validation Reports for Clinical Research Organisations
TrialKey provides CROs with AI-driven biostatistical validation reports, optimising clinical trial success through data-driven insights and strategies.
Read More 
Opyl Signs Landmark Binding Joint Venture with X Firm Ltd
Melbourne, Australia – Opyl Limited (ASX: OPL or “the Company“) a leader in AI-powered clinical trial optimisation, is thrilled to announce a […]
Read More Opyl Signs New Partnership Agreement with NeuOrphan
TrialKey (ASX: OPL) has entered into a Service Level Agreement (SLA) with Southern Clinical Development Consulting (Southern CDC) to enhance Southern CDC’s capabilities in clinical trial support and optimisation
Read More Opyl Launches AI-Powered AI-Biotech Investment Fund Targeting the US and Australia with Strategic Global Expansion Plans
TrialKey (ASX: OPL) has entered into a Service Level Agreement (SLA) with Southern Clinical Development Consulting (Southern CDC) to enhance Southern CDC’s capabilities in clinical trial support and optimisation
Read More 
TrialKey free database for specialists and researchers
Unlock free clinical trial data for GPs, specialists, and researchers with TrialKey’s comprehensive database of 30 years of insights.
Read More TrialKey Signs Service Level Agreement with Southern Clinical Development Consulting (Southern CDC)
TrialKey (ASX: OPL) has entered into a Service Level Agreement (SLA) with Southern Clinical Development Consulting (Southern CDC) to enhance Southern CDC’s capabilities in clinical trial support and optimisation
Read More 
Clinical Success with AI-Driven Biostatistical Validation
Unlocking Clinical Success: How TrialKey’s Recommendations Are Revolutionising Trial Design with 30 Years of Data In clinical research, precision and evidence are […]
Read More 
Opyl Enters Strategic Partnership with Phenix Health’s The Compendium
Discover TrialKey's non-exclusive strategic partnership with Alithia Life Sciences, a well-recognised CRO specialising in advanced clinical research solutions.
Read More Certainty in clinical trials starts here.
TrialKey stands as the market leader for clinical trial prediction and design optimization, with an accuracy rate of +90%
